Document is current

Any future updates will be listed below

Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy

Crossref DOI link: https://doi.org/10.1186/s12935-020-01609-w

Published Online: 2020-10-28

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark